Clinical trial
Maintenance Alemtuzumab in Refractory Chronic Lymphocytic Leukemia
NCT00587847 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Maintenance Alemtuzumab in Refractory Chronic Lymphocytic Leukemia
- Lead sponsor
- Northwell Health
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- August 31, 2005
- Completion date
- November 30, 2009
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic lymphocytic leukemia